Age and quality of life in patients with rheumatoid arthritis treated with biologic agents

References

• Miwa Y, Yajima N, Shiozawa F, Yoda Y, Hanaoka R, Hanyuda M. Relationship between psychological factors and arthralgia in patients with rheumatoid arthritis. Mod Rheumatol. 2002;12(1):32–6.
   PubMedGoogle Scholar
• Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. New Engl J Med. 2000;343(22):1586–93.
   PubMed Web of Science ®Google Scholar
• Cairns AP, Taggart AJ. Anti-tumor necrosis factor therapy for severe inflammatory arthritis: two years of experience in Northern Ireland. Ulster Med J. 2003;71:101–5.
   Google Scholar
• Miwa Y, Saito M, Furuya H, Yanai R, Ikari Y, Hayashi T, et al. Clinical characteristics of rheumatoid arthritis patients achieving functional remission after six months of non-tumor necrosis factor biological disease-modifying antirheumatic drugs (DMARDs) treatment. Intern Med. 2017;56(17):2271–5.
   PubMed Web of Science ®Google Scholar
• McPhail SM, Schippers M, Marshall AL. Age, physical inactivity, obesity, health conditions, and health-related quality of life among patients receiving conservative management for musculoskeletal disorders. Clin Interv Aging. 2014;9:1069–80.
   PubMed Web of Science ®Google Scholar
• Roma I, de Almeida ML, Mansano Nda S, Viani GA, de Assis MR, Barbosa PM. Quality of life in adults and elderly patients with rheumatoid arthritis (in Portuguese). Rev Bras Reumatol. 2014;54(4):279–86.
   PubMed Web of Science ®Google Scholar
• Radovits BJ, Kievit W, Fransen J, van de Laar MAFJ, Jansen TL, van Riel PLCM, Laan RFJM. Influence of age on the outcome of antitumour necrosis factor alpha therapy in rheumatoid arthritis. Ann Rheum Dis. 2009;68(9):1470–3.
   PubMed Web of Science ®Google Scholar
• Ortega-Valin L, Mayorga-Bajo I, Prieto-Fernandez C, Del PozoRuiz J, Gutierrez-Gutierrez E, Perez-Sandoval T. Long-term changes in the quality of life of patients with rheumatoid arthritis treated with biological therapies. Reumatol Clin. 2018;14(4):191–5.
   Google Scholar
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/Europian League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580–8.
   PubMed Web of Science ®Google Scholar
• Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol. 1998;51(11):1037–44.
   PubMed Web of Science ®Google Scholar
• Matsuda Y, Singh G, Yamanaka H, Tanaka E, Urano W, Taniguchi A, et al. Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3,763 patients with rheumatoid arthritis. Arthritis Rheum. 2003;49(6):784–8.
   PubMed Web of Science ®Google Scholar
• Drossaers-Bakker KW, de Buck M, van Zeben D, Zwinderman AH, Breedveld FC, Hazes JM. Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum. 1999;42(9):1854–60.
   PubMed Web of Science ®Google Scholar
• Mochizuki T, Yano K, Ikari K, Kawakami K, Hiroshima R, Momohara S. Relationship between achievement of physical activity goal and characteristics of patients with rheumatoid arthritis. Mod Rheumatol 2017;12:1–5.
   Google Scholar
• Nakajima A, Aoki Y, Terayama K, Sonobe M, Takahashi H, Saito M, Nakagawa K. Health assessment questionnaire-disability index (HAQ-DI) score at the start of biological disease-modifying antirheumatic drug (bDMARD) therapy is associated with radiographic progression of large joint damage in patients with rheumatoid arthritis. Mod Rheumatol. 2017;27(6):967–72.
   PubMed Web of Science ®Google Scholar
• van der Heijde DM, van 't Hof M, van Riel PL, van de Putte LB. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 1993;20:579–81.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33:S62–S9.
   PubMed Web of Science ®Google Scholar
• Andrassy K. Comments on 'KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney Disease'. Kidney Int. 2013;84(3):622–3.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Kremer JM, Gaich CL, DeLozier AM, Schlichting DE, Xie L, et al. Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON). Ann Rheum Dis. 2017;76(4):694–700.
   PubMed Web of Science ®Google Scholar
• Matcham F, Scott IC, Rayner L, Hotopf M, Kingsley GH, Norton S, et al. The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis. Semin Arthritis Rheum. 2014;44(2):123–30.
   PubMed Web of Science ®Google Scholar
• Kosinski M, Zhao SZ, Dedhiya S, Osterhaus JT, Ware JE. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum. 2000;43(7):1478–87.
   PubMed Web of Science ®Google Scholar
• Strand V, Singh J. Newer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity. Drugs. 2010;70(2):121–45.
   PubMed Web of Science ®Google Scholar
• Tang AC, Kim H, Crawford B, Ishii T, Treuer T. The use of patient reported outcome measures for rheumatoid arthritis in Japan: a systematic literature review. Open Rheumatol J. 2017;11(1):43–52.
   PubMedGoogle Scholar
• Schrag A. Quality of life and depression in Parkinson's disease. J Neurol Sci. 2006;248(1–2):151–7.
   PubMed Web of Science ®Google Scholar
• van den Broek M, Dirven L, Kroon HM, Kloppenburg M, Ronday HK, Peeters AJ, et al. Early local swelling and tenderness are associated with large-joint damage after 8 years of treatment to target in patients with recent-onset rheumatoid arthritis. J Rheumatol. 2013;40(5):624–9.
   PubMed Web of Science ®Google Scholar
• Natalini JG, Swigris JJ, Morisset J, Elicker BM, Jones KD, Fischer A, et al. Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease. Respir Med. 2017;127:1–6.
   PubMed Web of Science ®Google Scholar
• Targowski T. Sarcopaenia and rheumatoid arthritis. Reumatologia. 2017;55(2):84–7.
   PubMedGoogle Scholar
• Ngeuleu A, Allali F, Medrare L, Madhi A, Rkain H, Hajjaj-Hassouni N. Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors. Rheumatol Int. 2017;37(6):1015–20.
   PubMed Web of Science ®Google Scholar
• Mamoto K, Inui K, Okano T, Sugioka Y, Tada M, Koike T, et al. Incidence rate of falls and its risk factors in patients with rheumatoid arthritis compared to controls: Four years of the TOMORROW study. Mod Rheumatol. 2017;27(1):8–14.
   PubMed Web of Science ®Google Scholar
• Takayanagi N, Tsuchiya Y, Tokunaga D, Miyahara Y, Yamaguchi S, Saito H, et al. [Pulmonary infections in patients with rheumatoid arthritis]. Nihon Kokyuki Gakkai Zasshi. 2007;45:465–73.
   PubMedGoogle Scholar
• Attar SM, Alamoudi OS, Aldabbag AA. Prevalence and risk factors of asymptomatic bronchiectasis in patients with rheumatoid arthritis at a tertiary care center in Saudi Arabia. Ann Thorac Med. 2015;10(3):176–80.
   PubMed Web of Science ®Google Scholar
• Omachi T, Sarkar U, Yelin E, Blanc P, Katz P. Lower health literacy is associated with poorer health status and outcomes in chronic obstructive pulmonary disease. J Gen Intern Med. 2013;28(1):74–81.
   PubMed Web of Science ®Google Scholar
• Sudore R, Yaffe K, Satterfield S, Harris T, Mehta K, Simonsick E, et al. Limited literacy and mortality in the elderly: the health, aging, and body composition study. J Gen Intern Med. 2006;21(8):806
   PubMed Web of Science ®Google Scholar
• Matcham F, Scott IC, Rayner L, Hotopf M, Kingsley GH, Norton S, et al. The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis. Semin Arthritis Rheum. 2014;44(2):123–30.
   PubMed Web of Science ®Google Scholar
• Buija L, Tan J, Sanders KM, et al. Associations between illness duration and health-related quality of life in specified mental and physical chronic health conditions: results from a population-based survey. Qual Life Res. 2017;26(10):2671–81.
   PubMed Web of Science ®Google Scholar